Works matching IS 03407004 AND DT 2017 AND VI 66 AND IP 1
Results: 14
Tumor-directed immunotherapy can generate tumor-specific T cell responses through localized co-stimulation.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 1, doi. 10.1007/s00262-016-1909-3
- By:
- Publication type:
- Article
A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 25, doi. 10.1007/s00262-016-1913-7
- By:
- Publication type:
- Article
Effective induction of cytotoxic T cells recognizing an epitope peptide derived from hypoxia-inducible protein 2 (HIG2) in patients with metastatic renal cell carcinoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 17, doi. 10.1007/s00262-016-1915-5
- By:
- Publication type:
- Article
Low-dose interleukin-2 impairs host anti-tumor immunity and inhibits therapeutic responses in a mouse model of melanoma.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 9, doi. 10.1007/s00262-016-1916-4
- By:
- Publication type:
- Article
Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 45, doi. 10.1007/s00262-016-1918-2
- By:
- Publication type:
- Article
High-efficiency lysis of cervical cancer by allogeneic NK cells derived from umbilical cord progenitors is independent of HLA status.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 51, doi. 10.1007/s00262-016-1919-1
- By:
- Publication type:
- Article
Alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 can support immune responses toward tumors overexpressing ganglioside D3 in mice.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 63, doi. 10.1007/s00262-016-1920-8
- By:
- Publication type:
- Article
Neutrophils from chronic lymphocytic leukemia patients exhibit an increased capacity to release extracellular traps (NETs).
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 77, doi. 10.1007/s00262-016-1921-7
- By:
- Publication type:
- Article
Phase I-II study of lenalidomide and alemtuzumab in refractory chronic lymphocytic leukemia (CLL): effects on T cells and immune checkpoints.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 91, doi. 10.1007/s00262-016-1922-6
- By:
- Publication type:
- Article
Immunological effects of a novel RNA-based adjuvant in liver cancer patients.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 103, doi. 10.1007/s00262-016-1923-5
- By:
- Publication type:
- Article
Increased PD-L1 and T-cell infiltration in the presence of HLA class I expression in metastatic high-grade osteosarcoma: a rationale for T-cell-based immunotherapy.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 119, doi. 10.1007/s00262-016-1925-3
- By:
- Publication type:
- Article
Efficacy and toxicity of rechallenge with combination immune checkpoint blockade in metastatic melanoma: a case series.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 113, doi. 10.1007/s00262-016-1926-2
- By:
- Publication type:
- Article
A novel three-dimensional heterotypic spheroid model for the assessment of the activity of cancer immunotherapy agents.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 129, doi. 10.1007/s00262-016-1927-1
- By:
- Publication type:
- Article
Heterogeneity of CD8 tumor-infiltrating lymphocytes in non-small-cell lung cancer: impact on patient prognostic assessments and comparison of quantification by different sampling strategies.
- Published in:
- Cancer Immunology, Immunotherapy, 2017, v. 66, n. 1, p. 33, doi. 10.1007/s00262-016-1908-4
- By:
- Publication type:
- Article